Is there an association between PONV and chemotherapy-induced nausea and vomiting?

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 6, 2013, Pages 749-753

  Oddby Muhrbeck, E ^a   Obrink E ^a   Eksborg, S ^b   Rotstein, S ^b   Lonnqvist P A ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWEDEN;

ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BETAMETHASONE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE RESISTANCE; DROPERIDOL; EPIRUBICIN; FEMALE; FLUOROURACIL; GRANISETRON; HUMANS; MASTECTOMY; METHOTREXATE; METOCLOPRAMIDE; MIDDLE AGED; MODELS, BIOLOGICAL; NARCOTICS; NAUSEA; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; RISK FACTORS; VOMITING;

EID: 84878890661     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12053     Document Type: Article

References (17)

1. Van Wijk MG, Smalhout B,. A postoperative analysis of the patient's view of anaesthesia in a Netherlands' teaching hospital. Anaesthesia 1990; 45: 679-682.
2. Watcha MF, White PF,. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-184.
3. Apfel CC, Greim CA, Haubitz I, Grundt D, Goepfert C, Sefrin P, Roewer N,. The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol Scand 1998; 42: 502-509.
4. Koivuranta M, Laara E, Snare L, Alahuhta S,. A survey of postoperative nausea and vomiting. Anaesthesia 1997; 52: 443-449.
5. Tramer MR,. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part II. Recommendations for prevention and treatment, and research agenda. Acta Anaesthesiol Scand 2001; 45: 14-19.
6. White PF, Watcha MF,. Postoperative nausea and vomiting: prophylaxis versus treatment. Anesth Analg 1999; 89: 1337-1339.
7. Scuderi PE, James RL, Harris L, Mims GR, 3rd,. Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment. Anesthesiology 1999; 90: 360-371.
8. Palazzo M, Evans R,. Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment. Br J Anaesth 1993; 70: 135-140.
9. Oddby-Muhrbeck E, Eksborg S, Helander A, Bjellerup P, Lindahl S, Lonnqvist PA,. Blood-borne factors possibly associated with post-operative nausea and vomiting: an explorative study in women after breast cancer surgery. Acta Anaesthesiol Scand 2005; 49: 1346-1354.
10. Morrow GR,. Chemotherapy-related nausea and vomiting: etiology and management. CA Cancer J Clin 1989; 39: 89-104.
11. Daniel WW,. Applied nonparametric statistics. Boston: PWS-KENT, 1990.
12. Apfel CC, Kranke P, Katz MH, Goepfert C, Papenfuss T, Rauch S, Heineck R, Greim CA, Roewer N,. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88: 659-668.
13. Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, Julie Ma G, Eldridge K, Hipple A, Evans JK, Horgan KJ, Lawson F,. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 2003; 97: 3090-3098.
14. Bhatnagar S, Gupta D, Mishra S, Srikanti M, Singh M, Arora R,. Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study. J Clin Anesth 2007; 19: 512-516.
15. Fasching PA, Kollmannsberger B, Strissel PL, Niesler B, Engel J, Kreis H, Lux MP, Weihbrecht S, Lausen B, Bani MR, Beckmann MW, Strick R,. Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. J Cancer Res Clin Oncol 2008; 134: 1079-1086.
16. Rueffert H, Thieme V, Wallenborn J, Lemnitz N, Bergmann A, Rudlof K, Wehner M, Olthoff D, Kaisers UX,. Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting? Anesth Analg 2009; 109: 1442-1447.
17. Zhang W, Yuan JJ, Kan QC, Zhang LR, Chang YZ, Wang ZY,. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia. Minerva Anestesiol 2010; 77: 33-39.